Science
Aggregate reporting consolidates data from multiple clinical studies to provide a clear overview of safety and efficacy trends. This process helps regulatory agencies, sponsors, and researchers make informed decisions by summarizing complex datasets into understandable reports. Effective aggregate reporting ensures compliance with guidelines and enhances transparency throughout the drug development lifecycle. By delivering timely, accurate summaries, it supports risk assessment and regulatory submissions, making it an essential tool for managing clinical trial information efficiently.